How Skandor engages.

AI Governance Assurance Review

3–4 weeks

An independent assessment of whether your AI governance framework is defensible under EU AI Act scrutiny and whether your leadership has adequate visibility of AI risk.
Designed for pharmaceutical and life sciences organisations deploying AI in clinical, commercial, or operational environments.

Scope includes

  • AI Act high-risk classification review for active systems

  • DPIA adequacy assessment for AI-driven data processing

  • Governance framework gap analysis

  • C-level reporting quality review

  • Senior management accountability mapping

  • Written assessment

Privacy & AI Governance De-risking

3–9 months

Senior advisory embedded into transformation programmes digital platform deployments, AI tool integrations, cloud migrations, EHDS data sharing arrangements ensuring GDPR obligations, AI Act conformity, and clinical governance are managed as integrated risk, not addressed after the fact.

Scope includes

  • Privacy and AI risk embedded into programme governance

  • Article 9 health data treatment and transfer analysis

  • Third-party and vendor AI governance oversight

  • DPIA execution for novel AI processing activities

  • Cross-border data flow assessment and documentation

  • Regulator-ready documentation and audit trail support

Senior Management Assurance

Annual retainer

Sustained senior advisory for Audit committees, and C-suite executives on privacy and AI governance accountability. Provides the independent perspective and the preparedness that regulators increasingly expect to see evidenced at the top.

Scope includes

  • Quarterly C-suite or audit committee briefings

  • Senior manager accountability and attestation support

  • Management information quality review on AI and privacy risk

  • Regulatory horizon monitoring for pharma and life sciences

  • Priority access for emerging regulatory questions

  • Preparation for supervisory authority engagements